{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:58:24Z","timestamp":1786679904961,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> This study evaluated the potential of high-molecular-weight hyaluronic acid (HHA) as an intratympanic (IT) drug delivery vehicle for dexamethasone (D) in treating acute hearing loss. We compared the efficacy, safety, and residence time of HHA to the standard-of-care IT drug delivery method.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Endoscopic examinations were used to track tympanic membrane (TM) healing post-IT injection. Micro-computed tomography (CT) was used to gauge drug\/vehicle persistence in the bulla air space. Histological analyses covered the middle ear, TM, and hair cell counts. Auditory brainstem responses (ABR) were used to measure hearing thresholds, while high-performance liquid chromatography (HPLC) was employed to quantify cochlear perilymph dexamethasone concentrations.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The HHA + D group had a notably prolonged drug\/vehicle residence time in the bulla (41 \u00b1 27\u00a0days) compared to the saline + D group (1.1 \u00b1 0.3\u00a0days). Complete TM healing occurred without adverse effects. Histology revealed no significant intergroup differences or adverse outcomes. Hearing recovery trends favored the HHA + D group, with 85.0% of ears showing clinically meaningful improvement. D concentrations in cochlear perilymph were roughly double in the HHA group.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> HHA is a promising vehicle for IT drug delivery in treating acute hearing loss. It ensures extended residence time, augmented drug concentrations in targeted tissues, and safety. These results highlight the potential for HHA + D to excel beyond existing standard-of-care treatments for acute hearing loss.<\/jats:p>","DOI":"10.3389\/fphar.2024.1294657","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:12:22Z","timestamp":1705378342000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss"],"prefix":"10.3389","volume":"15","author":[{"given":"Yu-Jung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ha","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Whan","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph","volume":"28","author":"Bird","year":"2007","journal-title":"Otol. Neurotol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/MAO.0b013e3182255933","article-title":"Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph","volume":"32","author":"Bird","year":"2011","journal-title":"Otol. Neurotol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599819859885","article-title":"Clinical practice guideline: sudden hearing loss (update)","volume":"161","author":"Chandrasekhar","year":"2019","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.3390\/ijms22115720","article-title":"Effect and biocompatibility of a cross-linked hyaluronic acid and polylactide-co-glycolide microcapsule vehicle in intratympanic drug delivery for treating acute acoustic trauma","volume":"22","author":"Cho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.biomaterials.2004.07.052","article-title":"Designing biodegradable multiblock PCL\/PLA thermoplastic elastomers","volume":"26","author":"Cohn","year":"2005","journal-title":"Biomaterials"},{"key":"B6","volume-title":"Controlled release formulations for treating hearing loss and method of preparing the same (South Korea Patent No. K. I. P. Office","author":"Dae-Jung","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000441833","article-title":"The sustained-exposure dexamethasone formulation OTO-104 offers effective protection against cisplatin-induced hearing loss","volume":"21","author":"Fernandez","year":"2016","journal-title":"Audiol. Neurootol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","article-title":"Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere\u2019s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial","volume":"133","author":"Garduno-Anaya","year":"2005","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpb.2020.03.005","article-title":"Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear","volume":"150","author":"Gausterer","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/MAO.0b013e31818599d5","article-title":"Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections","volume":"29","author":"Hill","year":"2008","journal-title":"Otol. Neurotol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"650884","DOI":"10.3389\/fneur.2021.650884","article-title":"High-molecular-weight hyaluronic acid vehicle can deliver gadolinium into the cochlea at a higher concentration for a longer duration: a 9.4-T magnetic resonance imaging study","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/pen.20581","article-title":"Preparation of diblock copolymers consisting of methoxy poly (ethylene glycol) and poly (\u03b5\u2010caprolactone)\/poly (L\u2010lactide) and their degradation property","volume":"46","author":"Hyun","year":"2006","journal-title":"Polym. Eng. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/01945998211012300","article-title":"Tympanic membrane perforation after intratympanic steroid injection: a systematic review and meta-analysis","volume":"166","author":"Kim","year":"2022","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.3346\/jkms.2023.38.e135","article-title":"Injectable poloxamer hydrogel formulations for intratympanic delivery of dexamethasone","volume":"38","author":"Le","year":"2023","journal-title":"J. Korean Med. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/MAO.0000000000003769","article-title":"Delivery of dexamethasone to the round window niche by saturated gelatin sponge for refractory sudden sensorineural hearing loss: a preliminary study","volume":"44","author":"Lei","year":"2023","journal-title":"Otol. Neurotol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"701002","DOI":"10.3389\/fphar.2021.701002","article-title":"Dual viscosity mixture vehicle for intratympanic dexamethasone delivery can block ototoxic hearing loss","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.2147\/IJN.S245188","article-title":"Artemisinin loaded mPEG-PCL nanoparticle based photosensitive gelatin methacrylate hydrogels for the treatment of gentamicin induced hearing loss","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/AUD.0b013e3181c351f2","article-title":"Drug delivery for treatment of inner ear disease: current state of knowledge","volume":"31","author":"McCall","year":"2010","journal-title":"Ear Hear"},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7874\/kja.2012.16.2.65","article-title":"Characteristics of adverse effects when using high dose short term steroid regimen","volume":"16","author":"Min","year":"2012","journal-title":"Korean J. Audiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000506535","article-title":"Biocompatibility and Therapeutic Effect of 3 intra-tympanic drug delivery vehicles in acute acoustic trauma","volume":"25","author":"Park","year":"2020","journal-title":"Audiol. Neurootol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/mao.0b013e3181f7aba3","article-title":"Intratympanic steroid therapy for sudden hearing loss: a review of the literature","volume":"32","author":"Seggas","year":"2011","journal-title":"Otol. Neurotol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7599\/hmr.2016.36.2.125","article-title":"Intratympanic steroid injection in tinnitus management","volume":"36","author":"Shim","year":"2016","journal-title":"Hanyang Med. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"014556132311700","DOI":"10.1177\/01455613231170090","article-title":"Local vs. systemic use of steroids for sudden deafness with diabetes: a Systematic review and meta-analysis","author":"Wang","year":"2023","journal-title":"Ear Nose Throat J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"118969","DOI":"10.1016\/j.carbpol.2021.118969","article-title":"Injectable glycol chitosan thermogel formulation for efficient inner ear drug delivery","volume":"278","author":"Yu","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jchromb.2010.11.003","article-title":"Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography\/tandem mass spectrometry","volume":"879","author":"Zhang","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.polymdegradstab.2007.07.012","article-title":"Enzymatic degradation of block copolymers obtained by sequential ring opening polymerization of l-lactide and \u025b-caprolactone","volume":"92","author":"Zhao","year":"2007","journal-title":"Polym. Degrad. Stab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345208","article-title":"Primary observation of early transtympanic steroid injection in patients with delayed treatment of noise-induced hearing loss","volume":"18","author":"Zhou","year":"2013","journal-title":"Audiol. Neurootol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1294657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:12:26Z","timestamp":1705378346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1294657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":27,"alternative-id":["10.3389\/fphar.2024.1294657"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1294657","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1294657"}}